Figure 1.
Model of classical and “nongenomic” actions of the estrogen receptor (ER). Estrogenic ligands (triangles) activate ER as a transcription factor (1) by inducing a conformational change(s) that leads
to nuclear translocation, dimerization, and binding to specific steroid receptor response elements (SRE) in promoters of primary
target genes. Activated ER recruits coactivators that are essential for assembly of a productive transcription complex at
the promoter. Alternatively, a subpopulation of ER associates in an estrogen-dependent manner (2) with cytoplasmic- and/or
cell membrane–signaling molecules including the tyrosine kinase Src. This extranuclear interaction promotes the Shc-Src-Raf–MAPK
kinase (MEK)–MAP kinase phosphorylation cascade. Because MAPK can directly (solid arrows) or indirectly (dashed arrows) activate
other transcription factors (TF), the MAP kinase pathway can potentially regulate distinct or complementary sets of genes
from those regulated by nuclear ER pathways. Estrogen-activated MAPK can also enhance the direct transcriptional activity
of ER by an autofeedback loop through phosphorylation of ER or ER-associated coactivators. The hexagon indicates an adaptor
protein.